Insulet Stock (NASDAQ:PODD)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$238.24

52W Range

$233.29 - $354.88

50D Avg

$261.58

200D Avg

$300.46

Market Cap

$16.81B

Avg Vol (3M)

$945.84K

Beta

1.44

Div Yield

PODD Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

3,900

IPO Date

May 15, 2007

Website

PODD Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 25	Dec 24	Dec 23
Drug Delivery	$34.10M	$38.90M	$36.00M
International Omnipod	$2.67B	$2.03B	$1.66B
Product, Omnipod	-	-	$1.66B
U.S. Omnipod	-	-	$1.25B

Fiscal year ends in Dec 25 | Currency in USD

PODD Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$2.71B	$2.07B	$1.70B
Operating Income	$473.80M	$308.90M	$220.00M
Net Income	$247.10M	$418.30M	$206.30M
EBITDA	$473.80M	$423.70M	$323.60M
Basic EPS	$3.51	$5.97	$2.96
Diluted EPS	$3.48	$5.78	$2.94

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 18, 26 | 8:00 AM

Q3 25Nov 06, 25 | 8:00 AM

Q2 25Aug 07, 25 | 8:00 AM

Peer Comparison

Ticker	Company
WAT	Waters Corporation
BIIB	Biogen Inc.
SNN	Smith & Nephew plc
PHG	Koninklijke Philips N.V.
ZBH	Zimmer Biomet Holdings, Inc.
WST	West Pharmaceutical Services, Inc.
DGX	Quest Diagnostics Incorporated
LH	Labcorp Holdings Inc.
STE	STERIS plc
DXCM	DexCom, Inc.